Hallmarks of Cancer & Molecular Mechanisms of Carcinogenesis

**1. The Conceptual Framework (Hanahan & Weinberg)** Carcinogenesis is a multistep process resulting from the accumulation of sequential, non-lethal genetic and epigenetic alterations. The acquired biological capabilities that allow tumor cells to survive, proliferate, and disseminate are summarized as the **Hallmarks of Cancer**: **2. The Core Biological Hallmarks** 1. **Self-Sufficiency in Growth Signals**: Tumor cells synthesize their own growth factor ligands (autocrine stimulation), overexpress growth factor receptors (e.g., **HER2/neu** amplification in breast carcinoma), or acquire gain-of-function mutations in intracellular signaling cascades (e.g., point mutation in **KRAS** at codon 12, or **BRAF V600E** in melanoma, constitutively activating the MAPK pathway). 2. **Insensitivity to Growth-Inhibitory Signals**: Loss-of-function mutations in tumor suppressor genes that govern cell cycle checkpoints: - *Retinoblastoma (RB) Gene*: The "Governor of the Cell Cycle"; normally sequesters E2F transcription factor; phosphorylation by Cyclin D-CDK4 releases E2F to permit G1 to S phase transition. - *TP53 Gene*: The "Guardian of the Genome"; stabilizes in response to DNA damage, upregulating p21 (CDK inhibitor) to arrest cells in G1 for DNA repair, or inducing apoptosis via BAX/PUMA if repair fails. Mutated in >50% of human cancers. 3. **Evasion of Programmed Cell Death (Apoptosis)**: Overexpression of anti-apoptotic proteins (**BCL-2** via t(14;18) translocation in Follicular Lymphoma), downregulation of pro-apoptotic BAX/BAK, or inactivation of death receptor signaling pathways (FAS/CD95). 4. **Limitless Replicative Potential (Immortality)**: Normal cells experience telomere shortening with each division, entering senescence. Cancer cells reactivate **Telomerase (TERT)** in 85–90% of cases, maintaining telomere length indefinitely. 5. **Sustained Angiogenesis**: Hypoxia stabilizes Hypoxia-Inducible Factor 1-alpha (HIF-1a), which drives the transcription of **Vascular Endothelial Growth Factor (VEGF)** and basic FGF, stimulating new, tortuous, leaky capillary sprouting. In Von Hippel-Lindau (VHL) syndrome, loss of VHL ubiquitin ligase leads to constitutive HIF-1a accumulation and hypervascular tumors. 6. **Tissue Invasion and Metastasis**: - *Dissociation of Tumor Cells*: Downregulation and loss of **E-Cadherin** intercellular adhesion molecules. - *Degradation of Extracellular Matrix*: Secretion of active matrix metalloproteinases (MMP-2, MMP-9 gelatinases) to cleave Type IV basement membrane collagen. - *Epithelial-to-Mesenchymal Transition (EMT)*: Upregulation of Snail and Twist transcription factors. 7. **Reprogramming Energy Metabolism (The Warburg Effect)**: Even in the presence of ample oxygen, cancer cells shift glucose metabolism toward aerobic glycolysis, converting pyruvate to lactate. This provides metabolic intermediates (nucleotides, amino acids, lipids) required for rapid cellular biomass synthesis. 8. **Evading Immune Destruction**: Upregulation of inhibitory immune checkpoint ligands (e.g., **PD-L1** binding to PD-1 on cytotoxic T cells, exhausting antitumor immune responses). **3. 📖 Standard Textbook Reference** * *Robbins and Cotran Pathologic Basis of Disease*, 10th Ed., Ch. 7: Neoplasia, pp. 268–325. * *Hanahan D, Weinberg RA*. Hallmarks of Cancer: The Next Generation. *Cell*, 144(5):646–674.